Squarepoint’s SQZ Biotechnologies Company SQZ Stock Holding History

Squarepoint’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,038	Closed	-$233K	–	3869
2021 Q1	$233K	Buy	+17,038	New	+$346K	﹤0.01%	2603

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's SQZ Position: Q2 2021 in Review

Squarepoint sold out of SQZ Biotechnologies Company (SQZ) in Q2 2021, closing a stake of 17,038 shares — an estimated $233K sold.

Squarepoint first reported a position in SQZ in Q1 2021 and held it in 1 quarter. The position peaked at $233K in Q1 2021. 49 funds tracked by Wall St. Rank hold SQZ as of Q2 2021.

Squarepoint reported no remaining SQZ Biotechnologies Company position as of Q2 2021 after selling out during the quarter.
Squarepoint sold 17,038 SQZ Biotechnologies Company shares in Q2 2021, an estimated $233K.
Squarepoint first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 1 quarter.
Squarepoint's SQZ Biotechnologies Company position peaked at $233K in Q1 2021.
49 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.